Cindy Jacobs

2022

In 2022, Cindy Jacobs earned a total compensation of $1.1M as President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 5% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$159,250
Option Awards$233,135
Salary$455,000
Stock Awards$268,450
Total$1,115,835

Jacobs received $455K in salary, accounting for 41% of the total pay in 2022.

Jacobs also received $159.3K in non-equity incentive plan, $233.1K in option awards and $268.5K in stock awards.

Rankings

In 2022, Cindy Jacobs' compensation ranked 2,811th out of 5,711 executives tracked by ExecPay. In other words, Jacobs earned more than 50.8% of executives.

ClassificationRankingPercentile
All
2,811
out of 5,711
51st
Division
Manufacturing
1,566
out of 3,109
50th
Major group
Chemicals And Allied Products
725
out of 1,410
49th
Industry group
Drugs
677
out of 1,311
48th
Industry
In Vitro and In Vivo Diagnostic Substances
13
out of 29
55th
Source: SEC filing on April 28, 2023.

Jacobs' colleagues

We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2022.

2022

John Bencich

OncoGenex Pharmaceuticals

Chief Executive Officer

2022

Richard Stewart

OncoGenex Pharmaceuticals

Chairman

News

You may also like